文献速递角膜与眼表疾病青光眼

奈他舒地尔治疗角膜出现网状大疱性上皮水肿病例系列

Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series.
PubMed 文献 · Am J Ophthalmol · 2020-04-11

该回顾性病例系列报告了5例患者使用奈他舒地尔后出现网状大疱性上皮水肿的临床过程,其中4例有角膜水肿病史或危险因素。停用奈他舒地尔后所有病例水肿均改善或消退,多数视力稳定或提高。

要点

  • 奈他舒地尔可能诱发网状大疱性上皮水肿,多发生于有角膜水肿病史者。
  • 停用奈他舒地尔后水肿均改善或消退,多数视力在数周内改善。
  • 2例患者同时接受手术干预,可能影响视力改善的归因。

核心结论

  • 奈他舒地尔治疗中出现网状大疱性上皮水肿者多数有角膜水肿病史或危险因素,停药后水肿均改善或消退。

研究设计与样本

  • 回顾性病例系列,来自单一学术中心,共5眼5例患者的6次发作。

主要发现

  • 5例患者中4例有受影响眼角膜水肿病史,第5例有前葡萄膜炎和前房青光眼引流装置等危险因素。
  • 6次发作中4次在开始奈他舒地尔时已有角膜水肿,通常位于角膜基质。
  • 6次发作中5次在出现大疱性上皮水肿时视力恶化,停药后所有病例视力稳定或改善。
  • 所有病例停药后网状大疱性上皮水肿改善或消退,多数患者在停药后数周内视力改善。

临床怎么用

  • 对有角膜水肿病史或危险因素的患者使用奈他舒地尔时,应警惕网状大疱性上皮水肿的发生。
  • 一旦出现网状大疱性上皮水肿,应考虑停用奈他舒地尔。

局限性

  • 回顾性病例系列,样本量小,来自单一中心。
  • 部分患者同时接受手术干预,可能影响视力改善的归因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the patient characteristics and the clinical course of an unusual reticular pattern of bullous epithelial corneal edema in a series of patients treated with netarsudil. DESIGN: Retrospective case series. METHODS: Case series at a single academic center where treatment with netarsudil produced a particular pattern of bullous epithelial corneal edema. RESULTS: Six episodes of reticular bullous epithelial corneal edema were identified in 5 eyes of 5 patients treated with netarsudil. A total of 4 of 5 patients had a history of corneal edema in the affected eye, and the fifth patient had risk factors for corneal edema including a history of anterior uveitis and an anterior chamber glaucoma drainage device. In 4 of 6 episodes, corneal edema was present, typically in the corneal stroma at the time of netarsudil initiation. In 5 of 6 cases, visual acuity worsened with onset of bullous epithelial edema, and in all cases, visual acuity stabilized or improved following discontinuation of netarsudil. In all cases, the reticular bullous epithelial edema improved or resolved after discontinuation of netarsudil. CONCLUSIONS: The patient characteristics and natural history of a particular pattern of reticular bullous epithelial edema in a series of patients treated with netarsudil once daily is reported. Most patients had a history of corneal edema or predisposing risk factors for corneal edema. All patients demonstrated improvement in bullous epithelial edema after netarsudil discontinuation. Visual acuity improved in most patients within weeks after discontinuation of netarsudil, although 2 patients also underwent surgical interventions that might have contributed to improved visual acuity.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Wisely CE, Liu KC, Gupta D, et al. Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series. Am J Ophthalmol. 2020. PMID: 32289295. doi:10.1016/j.ajo.2020.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。